Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Crestor and Zocor Drugs Linked to Muscle Degeneration, Rhabdomyolysis

July 15, 2011 8:42 am | by Bio-Medicine.Org | News | Comments

EDISON, N.J., July 15, 2011 /- Crestor and Zocor are widely-used prescription strength drugs designed to lower "bad cholesterol". Both drugs are classified as "statins", medicine which lowers blood cholesterol levels by inhibiting HMG-CoA reductase. This group of drugs has had a...

Coriell Institute Teams With IBM to Advance Personalized Medicine

July 15, 2011 3:40 am | by Bio-Medicine.Org | News | Comments

ARMONK, N.Y. and CAMDEN, N.J., July 15, 2011 /- IBM (NYSE: IBM ) today announced that Coriell Institute for Medical Research, the largest biobank of living human cells, is using IBM technology to advance its research of human genetic disease and to more efficiently maintain its massive...

Top U.S. Hypertension Hot Spots Revealed

July 12, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

DEERFIELD, Ill., July 12, 2011 /- A national analysis conducted by Sperling's BestPlaces, sponsored by Takeda Pharmaceuticals North America, Inc., identifies the nation's Hypertension Hot Spots, or cities that face the most challenges due to hypertension risk factors and complications....


TandemHeart Approved for Expanded Reimbursement

July 12, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, July 12, 2011 /- The TandemHeart circulatory support system has been granted expanded reimbursement coverage by NHIC, Corp., the Medicare Administrative Contractor (MAC) serving over 1.3 million beneficiaries and over 53,000 healthcare providers in the Northeast region of the...

Topaz Pharmaceuticals' Ivermectin Cream In Vitro Data Demonstrates Activity Against Head Lice Eggs

July 11, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

HORSHAM, Pa., July 11, 2011 /- In a study sponsored by Topaz Pharmaceuticals Inc., a privately held specialty pharmaceutical company, scientists from the University of Massachusetts, Amherst presented data showing that a 0.5% ivermectin (IVM) cream formulation was active against lice eggs...

Greenway Takes Leadership Role in Multiple Regional Extension Center Initiatives

July 11, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

CARROLLTON, Ga., July 11, 2011 /- Greenway Medical Technologies, Inc., provider of the integrated, single-database electronic health record (EHR), practice management and interoperability solution PrimeSUITE, has established industry leadership in the advancement and success of the...

Brockton Visiting Nurse Association Selects Cardiocom® Telehealth

July 11, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, July 11, 2011 /- Brockton Visiting Nurse Association, a 100 year old provider of home care services to the residents of Southeastern Massachusetts, announced that it has entered into a business relationship with Cardiocom to provide advanced home telehealth technology to...

Ascribe Listed Among Top Finalists for the 2011 Microsoft Public Sector – Health Partner of the Year Award

July 11, 2011 3:33 am | by RealWire | News | Comments

Bolton, UK — July 11th, 2011 — Today, Ascribe announced it has been selected as a finalist for the Microsoft Public Sector - Health Partner of the Year Award. "Ascribe is delighted to be recognised for our continuing partnerships with NHS organisations that use our products...


Injecting Stem Cells into the Heart Could Stop Chronic Chest Pain

July 10, 2011 8:33 pm | by Massachusetts Institute of Technology | News | Comments

Early research suggests that the treatment works by promoting blood vessel growth.

Stryker Announces Exclusive Collaboration With RegenLab

July 8, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, July 8, 2011 /- Stryker Joint Preservation, a business unit of Stryker's Orthopaedics group, today announced at the 2011 American Orthopaedic Society for Sports Medicine meeting that it has entered into an exclusive collaboration with RegenLab SA to distribute Stryker's...

Generex Provides Preliminary Results of Generex Oral-lynâ„¢ Clinical Trials in Patients with Type 1 Diabetes and Patients with Impaired Glucose Tolerance

July 8, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

WORCESTER, Mass. and TORONTO, July 8, 2011 /- Generex Biotechnology Corporation (OTC Bulletin Board: GNBT ) ( ) today announced preliminary clinical results of two major trials using the Generex Oral-lyn™ formulation that will be used for registration and marketing....

Accuray's CyberKnife and TomoTherapy Systems Highlighted at World Conference on Lung Cancer

July 7, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., July 7, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), the premier radiation oncology company, announced new clinical data highlighting the ability of its CyberKnife® Robotic Radiosurgery System and its TomoTherapy® Radiation Therapy System to treat a wide...

FDA Proposes New Policy for Some Diagnostic and Radiology Devices

July 7, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., July 7, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration issued a draft guidance today describing its intent to exercise enforcement discretion with respect to the premarket notification requirements for certain in vitro diagnostic and radiology...


Lupin Launches Additional Strengths of Generic Lotrel® Capsules

July 6, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

BALTIMORE, July 6, 2011 /- Lupin Pharmaceuticals, Inc. (LPI) announced today that the U.S. Food and Drug Administration (US FDA) has granted final approval for its Amlodipine / Benazepril 5mg/40mg, and 10mg/40mg capsules.  Commercial shipments of the product have already commenced....

Potential Mechanism of Action Identified for the Treatment of Major Depression With Trigeminal Nerve Stimulation (TNS) - The USB Port to the Brainâ„¢

July 5, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, July 5, 2011 /- NeuroSigma, a Los Angeles-based neuromodulation company, today announced that a recent Phase I clinical trial revealed that external Trigeminal Nerve Stimulation (eTNS™) increased regional cerebral blood flow in brain regions associated with depression...

Acute Coronary Syndrome (ACS) Drug Market

July 5, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, July 5, 2011 /- announces that a new market research report is available in its catalogue: Acute Coronary Syndrome (ACS) Drug Market ...

Wireless Technology Now Allows Diabetes Patients to Manage Their Disease Real-Time and On-the-Go

June 30, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

DALLAS, June 30, 2011 /- According to the Centers for Disease Control and Prevention, nearly 26 million adults and children in the United States -- or 8.3 percent of the population -- have diabetes. Imagine if this sizeable group was able to more easily manage their diabetes while at...

Stem Cell Assurance Announces the Launch of its Brown Fat Stem Cell Therapeutic and Cosmetic Platform Technology Program

June 30, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

JUPITER, Fla., June 30, 2011 /- Stem Cell Assurance, Inc. (SCLZ.PK ) ("SCA") today announced the launch of a platform technology that involves the use of brown fat for cell-based therapeutic/cosmetic purposes.  Through its brown fat program, SCA intends to develop treatments for...

Boston Scientific Announces U.S. and European Launch of Interlockâ„¢ - 35 Fibered IDCâ„¢ Occlusion System

June 30, 2011 4:34 am | by Boston Scientific | News | Comments

Detachable coils for peripheral embolization offer precise placement and control in coiling procedures

Golden Meditech FY2010-11 Annual Results

June 30, 2011 2:34 am | by Bio-Medicine.Org | News | Comments

HONG KONG, June 30, 2011 /PRNewswire-Asia-FirstCall/ -- Golden Meditech Holdings Limited ("Golden Meditech," together with its subsidiaries collectively as the "Group," - 801.HK; 910801.TW), a leading integrated healthcare enterprise in China, is pleased to announce the Group's annual...

FDA Consumer Health Information - FDA's MedWatch Safety Alerts: May 2011

June 28, 2011 10:36 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., June 28, 2011 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) has recently issued safety alerts about a number of products, including: (Logo: ) birth control pills that may increase the risk of blood...

New Study Shows Viability of Heart Pumps for Older Heart-Failure Patients

June 28, 2011 10:35 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, June 28, 2011 /- Results of a clinical research study at Sharp Memorial Hospital indicate that patients 70 years of age or older have good functional recovery, survival and quality of life at two years when undergoing left ventricular assist device (LVAD) therapy for heart...

InfraReDx rounds up $24M in new funding

June 28, 2011 5:32 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Burlington-based medical device firm InfraReDx Inc. said it has raised $24.1 million in a new equity offering, seven months after completing a $21 million equity round.

New Arrivals of Exercise & Health Care Equipment

June 27, 2011 11:32 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, June 27, 2011 /PRNewswire-Asia/ -- Shenzhen Wuzhou Changlian International Trading Co., a leading online distributor specializing in health care electronics & medical equipment, announces its new arrivals of exercise equipment and health care electronics, which have...

BioDrain Streamway® System Receives Positive Evaluations on Two Additional Units

June 27, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, June 27, 2011 /- BioDrain Medical, Inc. (OTCBB: BIOR, OTCQB: BIOR), producer of the FDA cleared Streamway® System for automated surgical fluid disposal, today announced that it has placed two additional units and that new evaluations are underway at surgical facilities...

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.